DK0655244T5 - Sammensætning på basis af aminosyrer til behandling af infektioner - Google Patents

Sammensætning på basis af aminosyrer til behandling af infektioner

Info

Publication number
DK0655244T5
DK0655244T5 DK94402420T DK94402420T DK0655244T5 DK 0655244 T5 DK0655244 T5 DK 0655244T5 DK 94402420 T DK94402420 T DK 94402420T DK 94402420 T DK94402420 T DK 94402420T DK 0655244 T5 DK0655244 T5 DK 0655244T5
Authority
DK
Denmark
Prior art keywords
cysteine
amino acids
proportion
composition based
treat infections
Prior art date
Application number
DK94402420T
Other languages
Danish (da)
English (en)
Other versions
DK0655244T3 (da
Inventor
Maurice Arnal
Francis Rose
Denis Breuille
Christiane Obled
Original Assignee
Agronomique Inst Nat Rech
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9452315&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0655244(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Agronomique Inst Nat Rech, Nestle Sa filed Critical Agronomique Inst Nat Rech
Application granted granted Critical
Publication of DK0655244T3 publication Critical patent/DK0655244T3/da
Publication of DK0655244T5 publication Critical patent/DK0655244T5/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/427Thiazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/01Hydrolysed proteins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DK94402420T 1993-10-28 1994-10-27 Sammensætning på basis af aminosyrer til behandling af infektioner DK0655244T5 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9312884A FR2711529B1 (fr) 1993-10-28 1993-10-28 Composition à base d'acides aminés destinée au traitement d'une infection ou d'une agression engendrant une réaction inflammatoire, chez les animaux et chez l'homme.

Publications (2)

Publication Number Publication Date
DK0655244T3 DK0655244T3 (da) 2002-08-05
DK0655244T5 true DK0655244T5 (da) 2008-10-13

Family

ID=9452315

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94402420T DK0655244T5 (da) 1993-10-28 1994-10-27 Sammensætning på basis af aminosyrer til behandling af infektioner

Country Status (9)

Country Link
EP (1) EP0655244B2 (es)
KR (1) KR950010884A (es)
AT (1) ATE216234T1 (es)
CA (1) CA2134380C (es)
DE (1) DE69430416T3 (es)
DK (1) DK0655244T5 (es)
ES (1) ES2171439T5 (es)
FR (1) FR2711529B1 (es)
PT (1) PT655244E (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999038507A1 (en) * 1998-01-30 1999-08-05 David George Le Couteur Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation
SK11212002A3 (sk) * 2000-02-04 2003-01-09 Soci�T� Des Produits Nestl� S.A. Použitie proteínového zdroja, spôsob zachovania syntézy mucínov v tele pacienta a výživový prípravok
EP1302115A1 (fr) * 2001-10-16 2003-04-16 Societe Des Produits Nestle S.A. Utilisation de cystathionine
JP2007522208A (ja) * 2004-02-12 2007-08-09 キャンピナ・ネダーランド・ホールディング・ビー.ブイ. チオールのホメオスタシスを改良するためのシステインリッチのペプチド
EP1890688A2 (en) * 2005-06-14 2008-02-27 Nestec S.A. Nutritional method
DE102006018293A1 (de) * 2006-04-20 2007-10-25 Fresenius Kabi Deutschland Gmbh Pädiatrische Aminosäurelösung zur parenteralen Ernäherung
EP2165713B1 (en) 2008-09-19 2012-11-14 Nestec S.A. Whey and thymus function
WO2011021926A1 (en) 2009-08-21 2011-02-24 N.V. Nutricia Regulating the amino acid pool used for the acute-phase protein synthesis
EP2444083A1 (en) 2010-10-21 2012-04-25 Nestec S.A. Cysteine and food intake
WO2024122796A1 (ko) * 2022-12-05 2024-06-13 의료법인 성광의료재단 아스파르트산을 유효성분으로 포함하는 패혈증의 예방 또는 치료용 약학적 조성물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2531204A1 (de) * 1975-07-12 1977-01-13 Fresenius Chem Pharm Ind L-aminosaeuregemische fuer parenterale oder orale anwendung
DE2946563A1 (de) * 1979-11-17 1981-05-21 B. Braun Melsungen Ag, 3508 Melsungen Aminosaeureloesung zur parenteralen infusion
DE3026368A1 (de) * 1980-07-11 1982-02-18 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Naehrloesung fuer die vollstaendige parenterale ernaehrung und fuer gesteigerte energieproduktion
US4604286A (en) * 1984-09-17 1986-08-05 Daigo Nutritive Chemicals, Ltd. Infusion solution for parenteral nutrition
EP0264953B1 (de) * 1986-10-24 1991-05-08 PFRIMMER KABI GMBH & CO. KG Verwendung von N, N'-bis-L-Aminosäure-L-cystinpeptiden in Aminosäure-Präparaten für orale und parenterale Ernährung
SE8704217D0 (sv) * 1987-10-29 1987-10-29 Vinnars Erik Ab Aminosyrakomposition for parenteral neringstillforsel
US5224409A (en) 1991-03-19 1993-07-06 Ashlock Company Apparatus for producing helical slices
US5214062A (en) 1992-04-08 1993-05-25 Clintec Nutrition Co. Method and composition for treating immune disorders, inflammation and chronic infections
AU6060694A (en) 1993-05-10 1994-11-17 Transcend Therapeutics, Inc Method for treating acquired immune deficiency syndrome

Also Published As

Publication number Publication date
PT655244E (pt) 2002-08-30
CA2134380A1 (en) 1995-04-29
ES2171439T5 (es) 2008-12-01
FR2711529B1 (fr) 1996-07-05
DE69430416T3 (de) 2009-01-22
DE69430416T2 (de) 2002-12-05
ES2171439T3 (es) 2002-09-16
DK0655244T3 (da) 2002-08-05
EP0655244B2 (fr) 2008-06-11
ATE216234T1 (de) 2002-05-15
FR2711529A1 (fr) 1995-05-05
DE69430416D1 (de) 2002-05-23
EP0655244A1 (fr) 1995-05-31
CA2134380C (en) 2010-06-22
KR950010884A (ko) 1995-05-15
EP0655244B1 (fr) 2002-04-17

Similar Documents

Publication Publication Date Title
DK2016950T3 (da) Farmaceutisk sammensætning omfattende et exendin-4-peptid
DE69839812D1 (de) Analoge des menschlichen interferon-alpha mit niedriger toxizität
GEP20074123B (en) Amino acids with affinity for the alpha−2−delta−protein
PE20000560A1 (es) Uso de peg-ifn-alfa y ribavirina para el tratamiento de hepatitis c cronica
ES2141229T3 (es) Productos farmaceuticos de proteinas y peptidos modificados.
RS20090086A (en) Nucleoside analogs with carobxamidine modified monocyclic base
DE59810596D1 (de) Humanes, rekombinantes interferon-beta mit verbesserter löslichkeit
DK0655244T3 (da) Sammensætning på basis af aminosyrer til behandling af infektioner
GEP20063763B (en) Thrombopoietin Receptor Modulating Peptide
ATE62407T1 (de) Geschmack abdeckende zusammensetzungen.
ATE69164T1 (de) Arzneimittel zur behandlung von uraemie.
MY124560A (en) Amino acid compositions and use thereof in immunosuppression
BG97123A (bg) Производни на човешка, стимулирана от жлъчните соли, липаза и фармацевтични състави на тяхна основа
ES2087337T3 (es) Composiciones de implantes que contienen una proteina, peptido o polipeptido biologicamente activos.
ATE233105T1 (de) Pharmazeutische zubereitung für die intravenöse oder intramuskuläre verabreichung von octreotid
UY24780A1 (es) Composiciones farmacéuticas estabilizadas a base de quinupristina y dalfopristina y su preparación.
FI942938A0 (fi) Soijaproteiini tai -hydrolysaatit farmaseuttisissa koostumuksissa bioaktiivisten peptidien suojana entsymaattista inaktivoitumista vastaan
EP1557466A4 (en) TUMOR ANTIGEN PROTEIN AND USE THEREOF
AU3693097A (en) Derivatives of somatostatin, amino acids or oligopeptides and their combination useful for promoting body growth
FR2710244B3 (fr) Composition diététique à base d'acides aminés essentiels.
SE9100284D0 (sv) Novel peptide
IT1247493B (it) Sali ad attivita' antiinfiammatoria, analgesica e antipiretica e composizioni farmaceutiche che li contengono
ITMI931822A1 (it) Composizioni farmaceutiche a base di nimesulide, somministrabili per via orale, non gastrolesive e/o a rilascio controllato
SE8700125L (sv) Korta peptider vid behandling av psoriasis och schizofreni